Topic

Illinois

A collection of 499 issues

Somatuline Depot (lanreotide) Approval with UnitedHealthcare in Illinois: Complete Guide to Prior Authorization, Appeals, and Forms

Answer Box: Somatuline Depot (lanreotide) is covered by UnitedHealthcare in Illinois but requires prior authorization, specialist consultation (endocrinologist/oncologist), and documented trial/failure of octreotide in most cases. Submit through the UnitedHealthcare Provider Portal for fastest processing (3-5 business days). If denied, you have 180 days to appeal internally, then
5 min read

How to Get Venclexta (Venetoclax) Covered by Aetna CVS Health in Illinois: Complete PA Guide and Appeal Process

Answer Box: Getting Venclexta (Venetoclax) Covered by Aetna CVS Health in Illinois Venclexta (venetoclax) requires prior authorization with Aetna CVS Health for CLL, SLL, and AML in Illinois. The fastest path to approval involves submitting complete clinical documentation including diagnosis confirmation, tumor lysis syndrome (TLS) monitoring plan, and prior therapy
6 min read

Aetna (CVS Health) Coverage Criteria for Joenja (leniolisib) in Illinois: What Counts as "Medically Necessary"?

Answer Box: Getting Joenja (leniolisib) Covered by Aetna (CVS Health) in Illinois Aetna (CVS Health) requires prior authorization for Joenja (leniolisib) with strict medical necessity criteria: genetic confirmation of APDS (PIK3CD or PIK3R1 mutation), patient age ≥12 years and weight ≥45 kg, and specialist prescriber (immunologist/hematologist). Fastest path: 1)
6 min read

How to Get Evkeeza (Evinacumab) Approved by Aetna CVS Health in Illinois: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Evkeeza Covered by Aetna CVS Health in Illinois Evkeeza (evinacumab) requires prior authorization from Aetna CVS Health for homozygous familial hypercholesterolemia (HoFH). The fastest path to approval: (1) Confirm HoFH diagnosis with genetic testing or clinical criteria, (2) Document failure of maximum-tolerated statin, ezetimibe, and PCSK9 inhibitor,
7 min read